Contraceptive Technology Update – December 1, 2012
December 1, 2012
View Issues
-
Next month: CTU Salary Survey results
-
Long-acting methods safe for teens — Include options in your counseling
When it comes to contraception, most teens choose contraceptive methods with relatively high typical use failure rates, such as withdrawal, condoms, and oral contraceptives (OCs). -
Abortion rates fall with free contraception
Just-published data from the Contraceptive CHOICE Project, conducted by researchers at Washington University School of Medicine at St. Louis, confirms that provision of contraception at no cost substantially reduced unplanned pregnancies and cut abortion rates by 62-78% over the national rate. -
When to resume or begin contraception post ECPs?
You have just prescribed the selective progesterone receptor modulator emergency contraceptive pill (ECP), ulipristal acetate (ella, Watson Pharma, Morristown, NJ), to the patient sitting in front of you. -
Ovarian cancer screens not beneficial to women
In new guidance, the U.S. Preventive Services Task Force recommends against screening for ovarian cancer in women. -
Teen Topics: What about boys and emergency contraception?
When the Food and Drug Administration (FDA) approved Plan B Emergency Contraception (EC) for over-the-counter use in 2006, it opened up a new way for young men to be involved in preventing unintended pregnancy. -
Concern is growing for UTI antibiotic resistance
Check your last 10 patient charts. Chances are at least one patient reported a urinary tract infection (UTI). What was your chosen method of treatment? -
STI Quarterly: Initiative for HIV vaccine research funded — Quest for a shot persists
Is development of a HIV vaccine still important with such established HIV prevention approaches as male and female condom use, voluntary medical male circumcision, and pre-exposure prophylaxis (PrEP) now in place to limit exposure to HIV and reduce infectiousness? -
STI Quarterly: HPV shot safety affirmed in teens, young women
New data confirms the safety of the quadrivalent human papilloma virus (HPV4) vaccine. -
STI Quarterly: Make plans to attend workshop on HIV & women
-
STI Quarterly: Register now: ARHP to hold contraception webinars